Drug Type Bispecific T-cell Engager (BiTE) |
Synonyms XMAB30819 |
Target |
Mechanism CD3 stimulants(T cell surface glycoprotein CD3 stimulants), ENPP3 inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Cell Carcinoma | Preclinical | - | - |